Chargement en cours...
Mechanism‐based treatment of cancer with immune checkpoint inhibitor therapies
Immune checkpoints are cell surface molecules that initiate regulatory pathways which have powerful control of CD8(+) cytolytic T cell activity. Antagonistic and agonistic antibodies engaging these molecules have demonstrated profound impact on immune activation and have entered clinical use for the...
Enregistré dans:
| Publié dans: | Br J Clin Pharmacol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8176998/ https://ncbi.nlm.nih.gov/pubmed/32323342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14316 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|